Mitral valve replacement in patients of rheumatic heart disease associated with immune thrombocytopenia.
Indian J Thorac Cardiovasc Surg
; 39(5): 516-521, 2023 Sep.
Article
em En
| MEDLINE
| ID: mdl-37609607
Immune thrombocytopenia in association with rheumatic heart disease is not commonly seen. Surgical management of rheumatic heart disease becomes more challenging in the presence of immune thrombocytopenia. The risk of complications increases manifold and judicious medical management before, during, and after surgery is imperative. We discuss two such cases, the complications we faced and the problems we anticipated before, and their prevention. Both patients were managed without using immunoglobulins or doing splenectomy. The literature on valve replacement in patients of immune thrombocytopenia and the implications of immune thrombocytopenia in the management of patients with rheumatic heart disease is also reviewed.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Risk_factors_studies
Idioma:
En
Revista:
Indian J Thorac Cardiovasc Surg
Ano de publicação:
2023
Tipo de documento:
Article
País de publicação:
Índia